Novartis India announced that the 76th Annual General Meeting(AGM) of the company will be held on 31 July 2024.Powered by Capital Market - Live News

Novartis India announced that the Board of Directors of the Company at its meeting held on 10 May 2024, has recommended a Final dividend of Rs.25 per share (i.e.500%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Novartis India declined 41.33% to Rs 14.68 crore in the quarter ended March 2024 as against Rs 25.02 crore during the previous quarter ended March 2023. Sales rose 6.62% to Rs 81.17 crore in the quarter ended March 2024 as against Rs 76.13 crore during the previous quarter ended March 2023.For the full year,net profit declined 17.58% to Rs 85.19 crore in the year ended March 2024 as against Rs 103.36 crore during the previous year ended March 2023. Sales declined 11.53% to Rs 335.07 crore in the year ended March 2024 as against Rs 378.74 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales81.1776.13 7 335.07378.74 -12 OPM %13.8112.24 -19.4817.18 - PBDT21.4725.39 -15 125.45121.44 3 PBT21.3323.31 -8 122.84115.38 6 NP14.6825.02 -41 85.19103.36 -18 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

The Board of Novartis India at its meeting held on 17 February 2024 took note of the communication received from Novartis AG, Holding Company & Promoter, regarding their intention to conduct a strategic review to unlock value of their shareholding in the Company. After some deliberations, the Board agreed to support Novartis AG, as may be required, in evaluating their strategic options. Powered by Capital Market - Live News